Table 1.
Patient Characteristic | No. | % |
---|---|---|
| ||
Sex | ||
Female | 24 | 53.3% |
Male | 21 | 46.6% |
| ||
Race | ||
White | 37 | 82.2% |
Black | 5 | 11.1% |
Other | 3 | 6.7% |
| ||
Age | ||
<14 years | 25 | 55.6% |
≥14 years | 20 | 44.4% |
| ||
Local or Metastatic | ||
Local | 26 | 57.8% |
Metastatic | 19 | 42.2% |
| ||
Primary Tumor Size at Diagnosis in Greatest Dimension | ||
<8cm | 20 | 44.4% |
≥ 8cm | 25 | 55.6% |
| ||
Osseous vs. Extra Osseous | ||
Osseous | 35 | 77.8% |
Extra Osseous | 10 | 22.2% |
| ||
Site Category | ||
Pelvis | 16 | 35.6% |
Trunk | 13 | 28.9% |
Head and Neck | 5 | 11.1% |
Extremity | 11 | 24.4% |
| ||
Planned Definitive Surgical Resection | ||
Upfront Resection | 7 | 41.2% |
Delayed Resection | 10 | 58.8% |
| ||
Metastatic Patients (n=19) | ||
Primary tumor size ≥ 8cm at diagnosis | 14 | 73.6% |
Pelvic location | 9 | 47.4% |
Surgical resection | 4 | 21% |
Metastatic site: | ||
Lung | 10 | 52.6% |
Bone Marrow | 8 | 42.1% |
Pleura | 2 | 10.5% |
Lymph Node | 4 | 21% |
Bone | 9 | 47.4% |